Oxford Nanopore Technologies

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology
gptkbp:award	gptkb:Queen's_Award_for_Enterprise
gptkbp:CEO	gptkb:Gordon_Sanghera
gptkbp:collaboratesWith	gptkb:University_of_Oxford gptkb:Wellcome_Trust
gptkbp:country	gptkb:United_Kingdom
gptkbp:founded	2005
gptkbp:founder	gptkb:Hagan_Bayley
gptkbp:headquarters_location	gptkb:Oxford,_England
gptkbp:industry	gptkb:biotechnology genomics
gptkbp:listedOn	gptkb:FTSE_250_Index
gptkbp:notableClient	research institutions clinical laboratories
gptkbp:notableFor	DNA sequencing epigenetics metagenomics RNA sequencing pathogen surveillance
gptkbp:numberOfEmployees	over 900
gptkbp:patent	nanopore-based sequencing
gptkbp:product	gptkb:Flongle gptkb:GridION gptkb:MinION gptkb:PromethION
gptkbp:revenue	£198.6 million
gptkbp:stockExchange	gptkb:London_Stock_Exchange
gptkbp:stockSymbol	ONT
gptkbp:technology	nanopore sequencing
gptkbp:website	https://nanoporetech.com
gptkbp:bfsParent	gptkb:Illumina
gptkbp:bfsLayer	5
https://www.w3.org/2000/01/rdf-schema#label	Oxford Nanopore Technologies